HealthCareTips blog: The US FDA has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).

The US FDA has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).

The US FDA has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).

submitted by /u/mvea
[link] [comments]

source https://www.reddit.com/r/Health/comments/e1ep1w/the_us_fda_has_granted_psilocybin_therapy_a/

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)